These results were further confirmed by a xenograft tumor model in which FOXO3 overexpression reduced tumor growth in vivo, accompanied by reduced miR-21 expression, elevation of SPRY2, and inhibition of ERK signaling. Here, FOXO3 is linked to neoplasm.